Your cart
There are no more items in your cart
Treatment and prevention of bacterial dysentery caused by Shigella flexneri serotypes 1, 2, 3, 4 and 6 and Shigella sonnei.
An important condition for effective phage therapy is the preliminary determination of the phage sensitivity of the pathogen.
Solution for oral and rectal administration
COMPOSITION: Sterile purified filtrate of phagolysates of bacteria S. flexneri 1, 2, 3, 4 serotypes not less than 10-8, S. flexneri 6 serotype not less than 10-6, S. sonnei not less than 10-7 - up to 1 ml.
The drug is intended for oral and rectal administration. For treatment, the drug is taken orally 3 times a day on an empty stomach 1 hour before meals from the first day of the disease for 7-10 days.
In case of dysentery, characterized by a mild colitis syndrome, and during the period of convalescence, a combination of two-time oral administration with a single rectal administration of a single age-related dose of the drug in the form of an enema after a bowel movement is recommended.
For preventive purposes, the drug is recommended for use during group diseases in organized groups and families. The optimal scheme of use is the daily intake of a single dose of age. The duration of taking the drug is determined by the conditions of the epidemiological situation.
An important condition for effective phage therapy is the preliminary determination of the phage sensitivity of the pathogen.
Solution for oral and rectal administration
COMPOSITION: Sterile purified filtrate of phagolysates of bacteria S. flexneri 1, 2, 3, 4 serotypes not less than 10-8, S. flexneri 6 serotype not less than 10-6, S. sonnei not less than 10-7 - up to 1 ml.
The drug is intended for oral and rectal administration. For treatment, the drug is taken orally 3 times a day on an empty stomach 1 hour before meals from the first day of the disease for 7-10 days.
In case of dysentery, characterized by a mild colitis syndrome, and during the period of convalescence, a combination of two-time oral administration with a single rectal administration of a single age-related dose of the drug in the form of an enema after a bowel movement is recommended.
For preventive purposes, the drug is recommended for use during group diseases in organized groups and families. The optimal scheme of use is the daily intake of a single dose of age. The duration of taking the drug is determined by the conditions of the epidemiological situation.
| AGE OF THE PATIENT | Dose of the drug (ml) | |
|---|---|---|
| ORAL | RECTAL | |
| 0 – 6 months | 5 | 10 |
| 6 – 12 months | 10-15 | 20 |
| 1-3 years | 15-20 | 20-30 |
| 3-8 years | 20-30 | 30-40 |
| 8 years and older | 30-40 | 50-60 |
4602784002803
$6.69
Out-of-Stock
Tap to zoom
